Full Text View
Tabular View
No Study Results Posted
Related Studies
An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption
This study has been completed.
Study NCT00217204   Information provided by McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
First Received: September 13, 2005   Last Updated: September 25, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cystic Fibrosis
Steatorrhea
Additional conditions recognized in this trial
Exocrine Pancreatic Insufficiency
Fibrosis
Malabsorption Syndromes
More general conditions related to this trial
Digestive System Diseases
Gastrointestinal Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Intestinal Diseases
Lung Diseases
Metabolic Diseases
Pancreatic Diseases
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
Pancrelipase microtablets
Additional drug interventions recognized in this trial
Pancrelipase
More general drug interventions related to this trial
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
McNeil Consumer &Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services